Methamphetamine (Meth) abuse can result in long-lasting psychosis and dependence. The nucleus accumbens (NAc), which controls psychomotor and reward behaviours, is an important interface between the limbic system and receives convergent projections from dopaminergic and glutamatergic terminals. This study investigated the involvements of dopaminergic and glutamatergic transmission in the development of Meth psychosis and dependence by using tyrosine hydroxylase heterozygous mutant (TH +/x ) mice and N-methyl-D-aspartate
Introduction
Methamphetamine (Meth) is a highly addictive drug of abuse and addiction to Meth has increased to epidemic proportions worldwide. Meth has both acute and longlasting effects on psychomotor behaviours (Robinson and Becker, 1986 ; Srisurapanont et al., 2003) . Chronic use of Meth causes long-term cognitive deficits in addition to psychiatric signs such as hallucinations and delusions, similar to the positive symptoms seen in schizophrenia (Ujike and Sato, 2004 ; Akiyama, 2006) .
In acute exposure, Meth also produces rewarding effects through activation of the mesolimbic dopaminergic systems. During chronic Meth exposure, molecular and cellular elements in various regions of the brain undergo slow adaptive changes which lead to the development of drug dependence, sensitization and psychosis (Kalivas and Stewart, 1991 ; Brown et al., 2002) . Behavioural sensitization is the consequence of drug-induced neuroadaptive changes in the nucleus accumbens (NAc). The NAc is an important interface between the limbic system, which controls motivational aspects of behaviour, and the motor system, which controls the execution of behaviours (Koob, 1992) . The NAc is responsible for the rewarding effects of drugs and receives convergent synaptic input from dopaminergic and glutamatergic terminals.
Dopaminergic and glutamatergic interactions in the NAc are thought to play a crucial role in both the development of drug dependence, sensitization and psychosis. For example, cocaine causes an increase in synaptic dopamine and glutamate levels in the NAc (Park et al., 2002) .
The up-regulation of the cyclic adenosine 3k, 5k-monophosphate (cAMP) pathway and alteration of dopamine receptor sensitivity occur in neurons of the locus coeruleus and NAc (Nestler, 2001) . Neuronal adaptations are also induced by relatively stable changes in gene expression mediated by transcription factors, including cAMP response element-binding protein (CREB), Fos and Jun (Ginty et al., 1994 ; Tao et al., 1998) . Therefore, changes in neurotransmission and the number of synaptic connections in individual neurons contribute to the behavioural abnormalities associated with drug addiction.
The N-methyl-D-aspartate (NMDA) receptor is one of the glutamate receptor types that play a key role in synaptic plasticity and neuronal development. The activation of the NMDA receptor leads to opening of the receptor-gated ion channels, thereby allowing Ca 2+ to enter the neuron where it participates in numerous processes, including the activation of protein kinases (Malenka et al., 2003) . Protein kinases such as Ca 2+ / calmodulin kinase II (CaMKII) have been reported to play an important role in various neuronal adaptive processes such as long-term potentiation, drug addiction and behavioural deficits (Enomoto et al., 2007 ; Mouri et al., 2007 ; Murai et al., 2007 ; Anderson et al., 2008) . NMDA receptors are heteromeric assemblies of NR 1 and NR2A-D subunits (Kö hr, 2006 ; Collingridge et al., 2009) . Although disruption of the NR2A subunit results in a reduction in NMDA receptor function and augmentation of mesolimbic dopaminergic function (Miyamoto et al., 2001) , the role of NR2A in the Meth-induced psychosis and dependence are still unknown.
The present study was designed to explore the functional relationship between dopaminergic and glutamatergic transmission in psychosis and dependence induced by repeated Meth treatment using tyrosine hydroxylase (TH) heterozygous mutant (TH +/x ) mice and NR2A knockout (NR2A x/x ) mice. We attempted to investigate :
(1) whether behavioural abnormalities such as behavioural sensitization, disruption of prepulse inhibition (PPI) and acquisition of rewarding effect are induced after repeated administration of Meth in TH +/x and NR2A
x/x mice ; (2) the glutamatergicrdopaminergic signalling pathways molecular interaction in the NAc of mice repeatedly treated with Meth.
Method and materials

Animals
Male C57BL/6J mice (Japan SLC Inc., Japan) aged 6-8 wk at the beginning of experiments were used. Mutant mice lacking TH and the NR2A subunit were provided by Professors K. Kobayashi (Kobayashi et al., 1995) and M. Misima (Sakimura et al., 1995) , respectively. They were housed in plastic cages, received food (CE2 ; Clea Japan Inc., Japan) and water ad libitum and were maintained on a 12-h light-dark cycle (lights on 08:00 hours).
Behavioural experiments were carried out in a soundattenuated and air-regulated experimental room, to which mice were habituated for at least 1 h. All experiments were performed in a blinded manner and in accordance with the Guidelines for Animal Experiments of Nagoya University Graduate School of Medicine. The procedures involving animals and their care conformed to the international guidelines set out in the National Institutes of Health's Guide for the Care and Use of Laboratory Animals.
Drug treatment
d-(S)-Methamphetamine hydrochloride (Meth : Dainippon Sumitomo Pharma Co. Ltd, Japan) and memantine (Sigma-Aldrich, USA) were dissolved in saline. Mice were subjected to a 7-d regimen in which Meth (1 mg/kg) was injected s.c. once daily for 7 d (Fig. 1) . Memantine (5 and 7.5 mg/kg) was administered i.p. 30 min before Meth treatment on day 7. The doses of memantine used in the present study were based on previously published data (Gao et al., 2011) and our own preliminary experiments. Namely, memantine has been shown to produce mania-like behaviour in rats at doses of 5 and 7.5 mg/kg (Gao et al., 2011) and decreased motor activity in mice at 10 mg/kg. (unpublished data). To avoid physical interaction between drugs, Meth (s.c.) and memantine (i.p.) were administered by distinct routes, as described previously (Camarasa et al., 2010) . Control animals were given the same volume of vehicle according to the same schedule as used for single and repeated administrations of Meth.
Locomotor activity
Mice were placed individually in a transparent acrylic cage with a black frosted Plexiglas 1 floor (30r 47.5r35 cm) and locomotor activity was measured every 5 min for 60 min using digital counters with an infrared sensor, SCANET SV-10 LD (Brainscience Idea, Japan). Each mouse was habituated to the test environment for 60 min before the measurement of locomotor activity. Mice were administered Meth (1 mg/kg s.c.) or saline once daily for 7 d. On days 1, 3, 5 and 7, each mouse was placed in a test cage immediately after treatment with Meth and 30 min later, locomotor activity was measured for 30 min (Fig. 1) . 
Conditioned place preference test
The conditioned place preference test was performed in accordance with the method of Noda et al. (1998) . The apparatus consisted of two compartments : a transparent Plexiglas 1 box and a black Plexiglas 1 box (both 15r15r15 cm high). To enable a mouse to distinguish the transparent box from the black one, the floors of the transparent and black boxes were covered with a white plastic mesh and with frosted Plexiglas 1 , respectively. In the pre-conditioning test, a mouse was allowed to move freely between both boxes for 15 min once daily for 3 d after treatment with Meth for 7 d (Fig. 1) . On day 10, the time the mouse spent in the transparent and black boxes was measured using a SCANET SV-10 LD (Brainscience Idea ; Fig. 1 ). The conditioning was performed over 6 d consecutively (Fig. 1) . On days 11, 13 and 15, the mouse was treated with Meth and confined for 20 min in the non-preferred box. This was the box in which the animal had spent less time than in the other (preferred) box during the pre-conditioning test. On days 12, 14 and 16, the mouse was given saline and confined in the preferred box for 20 min. On day 17, the post-conditioning test was performed without drug treatment and the time that the mouse spent in the transparent and black boxes for 15 min was measured as on day 10. Meth (1 mg/kg s.c.) was injected immediately before the conditioning test (Fig. 1) . Place conditioning behaviour was calculated as : [(post value) x (pre value)], where post and pre values were the difference in time spent at the drug-conditioning and the saline-conditioning sites in the post-conditioning and pre-conditioning tests, respectively.
Protein kinase A assay
Mice were administered Meth (1 mg/kg s.c.) or saline once daily for 7 d. On day 7, mice were killed 30 min after treatment with Meth and different areas of the brain were dissected and kept at x80 xC. Frozen NAc sections were placed in homogenization buffer (50 mM Tris pH 7.4, 100 ng/ml leupeptin, 100 ng/ml aprotinin and 5 mM EDTA) and homogenized using a hand-held Teflon homogenizer. Protein concentrations were determined with the Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, USA), using bovine serum albumin (BSA) as a standard.
Protein kinase (PK) A assay was performed using the Protein Kinase A Assay Kit (BIO-RAD, USA). Duplicate NAc homogenates containing 4 mg protein from each subject were incubated for 5 min at 30 xC in phosophorylation buffer (50 mM Tris pH 7.4, 10 mM MgCl 2 and 0.25 mg/ml BSA), containing 50 mg kemptide and 100 mg c-32 P (ICN, USA). In addition, the buffer contained either cAMP (10 mM) or PK inhibitor (I ; 6-22) amide (1 mM/reaction). Following incubation, the phosophorylation mixture was blotted on phosphocellulose filter paper. The filter paper was washed twice with 1 % phosphoric acid for 5 min, followed by two 5-min washes with distilled water. Filters were then placed in scintillation fluid and quantified by liquid scintillation spectrometry. cAMP-dependent PKA activity was defined as the difference between PKA activity in the presence of cAMP and that measured in the presence of PKI.
Western blotting
Mice were administered Meth (1 mg/kg s.c.) or saline once daily for 7 d. On day 7, mice were killed 30 min after treatment with Meth and different areas of the brain were dissected and kept at x80 xC. The dissected brain tissue was homogenized by sonication in ice-cold lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM sodium orthovanadate, 2 mM EDTA, 50 mM NaF, 0.1 % SDS, 1 % Nonidet P-40, 1 % sodium deoxycholate, 10 mg/ml pepstatin, 10 mg/ml aprotinin and 10 mg/ml leupeptin). The homogenate was centrifuged at 13 000 g for 20 min to pellet insoluble material. The protein concentration in the supernatant was determined using a Protein Assay Rapid Kit (Wako Pure Chemicals, Japan). The sample was boiled in a sample buffer [0.25 % Bromophenol Blue, 0.25 % Xylene Cyanol, 30 % glycerol and 20 % 2rTBE (90 mM Tris, 64.6 mM boric acid and 2.5 mM EDTA ; pH 8.4)] , subjected to SDS-polyacrylamide gel electrophoresis on a 4.75 % stacking gel and 10 % separating gel and then transferred electrophoretically to a polyvinylidene difluoride membrane (Millipore Corporation, USA). The same concentration (20 mg) of protein per lane was loaded for Western blotting. The membrane was incubated in the blocking solution (Kirkegaard and Perry Laboratories, USA) for 2 h at room temperature and then incubated with primary antibodies. After washing, blots were incubated with the secondary antibodies. Immunoreactive materials on the membrane were detected using ECL western blotting detection reagents (Amersham Biosciences Inc., USA) and exposed to X-ray film. The band intensities of the film were analysed by densitometry. To calculate the amount of the phosphorylated form of CaMKII and CREB vs. total protein, the same membranes were stripped with a stripping buffer (100 mM 2-mercaptoethanol, 2 % SDS and 62.5 mM TrisHCl, pH 6.7) at 50 xC for 20 min, incubated with primary antibodies for total protein and detected as described earlier.
Statistical analysis
The results are expressed as mean¡S.E.M. for each group. Statistical significance was determined using a one-way analysis of variance (ANOVA), followed by the Bonferroni's test for multi-group comparisons. Statistical differences between two sets of groups were determined by paired t test. Probability values p<0.05 were taken to indicate statistically significant differences.
Results
Effect of repeated administration of Meth on locomotor activity in wild-type, TH
+/x and NR2A x/x mice Figure 2 shows the effect of repeated administration of Meth on the locomotor activity of wild-type, TH
and NR2A x/x mice. In wild-type mice, single Meth treatment (on day 1 ; 1 mg/kg dose ) caused a marked increase in locomotor activity and repeated administration for 7 d resulted in a time-dependent enhancement of the locomotor-stimulating effect of Meth (one-way ANOVA : F 7,72 =20.31, p<0.05). By day 7, Meth-induced hyperlocomotion was significantly potentiated compared to that observed on day 1, indicating behavioural sensitization to Meth (p<0.01 by post hoc, Fig. 2 ). TH
and NR2A
x/x mice also showed an increase in loco- Meth treatment had no effect on the startle amplitude in wild-type, TH +/x and NR2A x/x mice (data not shown).
As shown in Fig. 3 (b) , Meth (0.3 mg/kg s.c.) failed to induce place preference in wild-type mice pre-treated with saline, whereas wild-type mice repeatedly pretreated with Meth for 7 d showed rewarding effects of Meth in the conditioned place preference test. Methinduced conditioned place preference was significantly attenuated in TH +/x and NR2A (Fig. 4) .
Changes in phosphorylation of CaMKII and CREB in the NAc after repeated Meth treatment
Because the CaMKII/CREB signalling pathway involving dopamine/NMDA receptors plays an important role in Meth-induced behavioural sensitization and rewarding effects (Nestler, 2001 However, they did not increase above basal levels in TH +/x and NR2A x/x mice repeatedly treated with
Meth. There was no difference in the levels of phosphorylated CaMKII and CREB in wild-type and mutant mice repeatedly treated with saline (Fig. 5) .
Effect of memantine on the expression of Meth-induced behavioural sensitization in wild-type mice
We investigated the ability of memantine to prevent the expression of behavioural sensitization to Meth in wild-type mice. As shown in Fig. 6 On day 7, animals were placed in the test chamber immediately after the treatment with Meth, and their startle response was measured using an SR-LAB startle chamber for 10 min after the last injection. PPI ( %) at four different prepulse intensities (64, 68 and 76 dB mice, Meth-induced hyperlocomotion on day 7 was significantly potentiated when compared to that observed on day 1, indicating behavioural sensitization. In Meth-treated mice, administration of memantine (5 and 7.5 mg/kg i.p.) 15 min before the last injection of Meth on day 7 (7.5 mg/kg), prevented the expression of behavioural sensitization to Meth (one-way ANOVA : F 7,44 =15.84, p<0.05 ; p<0.01 by post hoc analysis). Memantine failed to affect hyperlocomotion induced by single Meth treatment (data not shown).
Discussion
Behavioural sensitization refers to the progressive augmentation of behavioural responses to a psychomotor stimulant, which develops during their repeated administration and persists even after long periods of withdrawal (Featherstone et al., 2007) . Behavioural sensitization induced by repeated Meth treatment is highly relevant to psychological dysfunction including rewarding effects in Meth abusers because the form of psychosis seen in Meth abusers is enduring and is not usually accompanied by transient confusion (Grant et al., 2012) . Behavioural sensitization in rodents is typically characterized by hyperlocomotion (Maehara et al., 2008 ; Kuczenski et al., 2009) . We have reconfirmed that wild-type mice repeatedly treated with Meth show behavioural sensitization to Meth consistent with previous reports (Fig. 2) . We also found that Meth-sensitized mice, but not wild-type mice repeatedly treated with saline, exhibited impairment of PPI after Meth (1 mg/kg) treatment and acquisition of rewarding effect of Meth (0.3 mg/kg) in the conditioned place preference test (Fig.  3) . These findings provide evidence that wild-type mice develop behavioural abnormalities, such as sensitization, PPI deficits and reward behaviour following repeated Meth treatment.
Behavioural sensitization research has been based on the idea that adaptations in dopaminergic systems must play a primary role in behavioural sensitization. Behavioural sensitization to Meth did not develop in the TH +/x mice (Fig. 2) , suggesting that catecholaminergic systems are involved in the development of Methinduced behavioural sensitization, since TH is the first and the rate-limiting enzyme in the catecholamine biosynthetic pathway (Kobayashi et al., 1995) . In this mouse strain, the levels of noradrenaline and dopamine were decreased 20-30 % and 30-40 %, respectively, compared with wild-type control mice. We previously demonstrated that Meth-induced behavioural sensitization is prevented by co-administration of the TH inhibitor, a-methyl-r-tyrosine (AMPT ; 50 mg/kg ; Noda et al., 1998). Analysis of the neurochemical effects of AMPT treatment revealed a marked decrease in dopamine levels and no reduction in noradrenaline and serotonin levels in the brain. It had been shown that the dopaminergic systems play an important role in behavioural sensitization to Meth. Recent studies on glutamatergic systems have demonstrated that the selective NMDA receptor antagonist dizocilpine blocks sensitization to Meth-and cocaineinduced hyperlocomotion but produces sensitization to its own hyperlocomotive effects (Karler et al., 1989 ; Wolf and Jeziorski, 1993 ; Kim and Jang, 1997 . Co-administration of dizocilpine also inhibits behavioural sensitization as assessed based on cellular characteristics, such as dopamine-D 2 autoreceptor subsensitivity and increased TH immunoreactivity in the ventral tegmental area, dopamine-D 1 receptor supersensitivity and augmentation of dopamine releasability in the NAc and increased calmodulin content in the striatum (Nestler and Aghajanian, 1997 ; Hara and Pickel, 2008) . These results support the hypothesis that NMDA receptor transmission is an early requirement in the cascade of cellular changes leading to sensitization. We found that behavioural sensitization to Meth did not develop in NR2A
x/x mice (Fig. 2) . Since NR2A
x/x mice exhibit a reduction in NMDA receptor functions such as a decrease in [ 3 H] dizocilpine specific binding and Ca 2+ uptake into synaptosome stimulated by glutamine or glycine, the fact that sensitization to Meth does not develop in NR2A
x/x mice may be due to an inability to counteract the inhibition of dopaminergic systems elicited by Meth (Miyamoto et al., 2001) . These findings are consistent with a preferential role for NMDA receptors in the development of sensitization to Meth.
In addition to behavioural sensitization, TH +/x and NR2A x/x mice did not show an intensity-dependent impairment of PPI and the rewarding effects of Meth, compared with wild-type mice repeatedly treated with Meth (Fig. 3) . It is unlikely that the lack of PPI deficits and rewarding effects of Meth are a consequence of a difference in the levels of startle amplitude and of place preference between wild-type and both mutant mice, since repeated Meth treatment had no effect on the startle amplitude and there was no difference in place preference among wild-type and mutant mice repeatedly treated with saline (Fig. 3) . These findings suggest that there is a common molecular mechanism in the development of behavioural sensitization and behavioural abnormalities including PPI deficit and the rewarding effect induced by Meth. Dopamine and glutamate have been shown to extensively interact in the NAc to regulate different physiological functions, including locomotor activity, positive reinforcement and attention. Post-synaptic dopaminerglutamate receptor interactions on medium spiny neurons are critical for both the acute and chronic effects of psychostimulants (Malenka, 2003 ; Jones and Bonci, 2005) . It is possible that repeated Meth treatment impairs PPI and triggers rewarding effects of Meth through a malfunction of the dopamine/NMDA receptor-associated signalling pathways in the NAc, which depend on post-synaptic function in dopaminergicglutamatergic systems. In fact, it is well established that NMDA receptor sensitivity is regulated by dopamine at the postsynaptic level in the NAc. The dopamine-D 1 receptor is coupled to Gs proteins, which activate adenyl cyclase, increase cAMP levels and phosphorylate PKA and Ser 897 of the NR1 subunit, which is a substrate of PKA (Tingley et al., 1997) . It has been also reported that a dopamine-D 1 agonist, but not a D 2-receptor agonist, causes phosphorylation of NR1 via activation of PKA (Snyder et al., 1999) . Among NR2 subunits, NR2A rather than NR2B plays a critical role in plastic synaptic changes induced by dopamine and amphetamine in the NAc (Chergui, 2011) . In the present study, we found that factors downstream of NMDA receptor activation such as Ca 2+ influx, CaMKII and CREB phosphorylation were activated by repeated Meth treatment. Interestingly, we found that PKA activity and the levels of phosphorylated CaMKII and CREB were increased in the NAc of mice showing behavioural sensitization to Meth (Figs. 4 and 5) . These results suggest that the PKA/CaMKII/CREBdependent signal cascade is involved in the development of behavioural sensitization to Meth (Fig. 7) S a l / S a l M e t h / S a l M e t h / M e m a n t i n e 5 M e t h / M e m a n t i n e 7 . 5 S a l / S a l M e t h / S a l M e t h / M e m a n t i n e 5 M e t h / M e m a n t i n e 7 . 5
Day 7 Meth, did not result in activation of this signal cascade (Fig. 7) , suggesting that the enhancement of both dopaminergic and glutamatergic activity is required for the acquisition of behavioural sensitization. Meth abusers show cortical damages and impairments of cognition and attention (Paulus et al., 2002) . Methinduced sensitization is a type of neuroplasticity relevant to drug addiction and to the cognitive deficits caused by Meth abuse, which has been widely prevalent in recent years (Kalechstein et al., 2003 ; Nordahl et al., 2003) . Indeed, repeated Meth treatment induces cognitive deficit, which persists for at least 28 d after withdrawal (Kamei et al., 2006 ; Noda et al., 2010) . Further studies are needed to determine the effect of repeated Meth treatment on cognitive function in TH +/x and NR2A
x/x mice and the involvement of dopaminergic and glutamatergic systems in Meth-induced cognitive impairment. However, both TH +/x and NR2A x/x mice show cognitive impairments in learning and memory tests (Kobayashi et al., 2000 ; Miyamoto et al., 2001) . Thus, the efficacy of dopamine-and NMDA-receptor antagonists on the cognitive impairment induced by repeated Meth treatment should be further investigated in future studies. We investigated the efficacy of memantine in preventing the expression of behavioural sensitization to Meth in wild-type mice. The positive results in this study suggest that memantine could be the first effective drug for preventing the development of PPI impairment and dependence. The expression of behavioural sensitization to Meth in wild-type mice was significantly prevented by single administration of memantine with Meth on day 7 without affecting hyperlocomotion induced by single Meth treatment (Fig. 6) . Our findings clearly demonstrate that repeated Meth treatment activated NMDA function mediated via dopaminergic-PKA signalling and that NMDA receptors play an important role in Meth place conditioning. The effectiveness of systemically administered memantine in attenuating the rewarding effects of Meth and other drugs of abuse suggests that it may be a useful therapeutic agent for the treatment of drug addiction.
The present study established a functional dopaminergicrglutamatergic transmission interaction in Methinduced psychosis. We demonstrated that Meth-induced psychosis was markedly attenuated in TH +/x and NR2A x/x mice compared with wild-type mice, suggesting that Meth-induced activation of dopaminergic and glutamatergic transmission in the brain plays a role in the development of Meth-induced sensitization, disruption of PPI and Meth reward, which may be associated with neuronal plasticity and drug addiction. 
